The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sophocarpidine Market Research Report 2024
Synopsis
Sophocarpidine (CAS：519-02-8) is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
The global Sophocarpidine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Sophora flavescens Aiton is mainly distributed in Cina, India, Japan, North Korea, Siberia, Russia.
This report aims to provide a comprehensive presentation of the global market for Sophocarpidine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sophocarpidine.
Report Scope
The Sophocarpidine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sophocarpidine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sophocarpidine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Segment by Type
High Purity
Low Purity
Segment by Application
Pharmaceuticals
Pesticides
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sophocarpidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sophocarpidine (CAS：519-02-8) is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
The global Sophocarpidine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Sophora flavescens Aiton is mainly distributed in Cina, India, Japan, North Korea, Siberia, Russia.
This report aims to provide a comprehensive presentation of the global market for Sophocarpidine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sophocarpidine.
Report Scope
The Sophocarpidine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sophocarpidine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sophocarpidine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Segment by Type
High Purity
Low Purity
Segment by Application
Pharmaceuticals
Pesticides
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sophocarpidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sophocarpidine Market Overview
1.1 Product Overview and Scope of Sophocarpidine
1.2 Sophocarpidine Segment by Type
1.2.1 Global Sophocarpidine Market Value Comparison by Type (2024-2030)
1.2.2 High Purity
1.2.3 Low Purity
1.3 Sophocarpidine Segment by Application
1.3.1 Global Sophocarpidine Market Value by Application: (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Pesticides
1.3.4 Others
1.4 Global Sophocarpidine Market Size Estimates and Forecasts
1.4.1 Global Sophocarpidine Revenue 2019-2030
1.4.2 Global Sophocarpidine Sales 2019-2030
1.4.3 Global Sophocarpidine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sophocarpidine Market Competition by Manufacturers
2.1 Global Sophocarpidine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sophocarpidine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sophocarpidine Average Price by Manufacturers (2019-2024)
2.4 Global Sophocarpidine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sophocarpidine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sophocarpidine, Product Type & Application
2.7 Sophocarpidine Market Competitive Situation and Trends
2.7.1 Sophocarpidine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sophocarpidine Players Market Share by Revenue
2.7.3 Global Sophocarpidine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sophocarpidine Retrospective Market Scenario by Region
3.1 Global Sophocarpidine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sophocarpidine Global Sophocarpidine Sales by Region: 2019-2030
3.2.1 Global Sophocarpidine Sales by Region: 2019-2024
3.2.2 Global Sophocarpidine Sales by Region: 2025-2030
3.3 Global Sophocarpidine Global Sophocarpidine Revenue by Region: 2019-2030
3.3.1 Global Sophocarpidine Revenue by Region: 2019-2024
3.3.2 Global Sophocarpidine Revenue by Region: 2025-2030
3.4 North America Sophocarpidine Market Facts & Figures by Country
3.4.1 North America Sophocarpidine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sophocarpidine Sales by Country (2019-2030)
3.4.3 North America Sophocarpidine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sophocarpidine Market Facts & Figures by Country
3.5.1 Europe Sophocarpidine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sophocarpidine Sales by Country (2019-2030)
3.5.3 Europe Sophocarpidine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sophocarpidine Market Facts & Figures by Country
3.6.1 Asia Pacific Sophocarpidine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sophocarpidine Sales by Country (2019-2030)
3.6.3 Asia Pacific Sophocarpidine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sophocarpidine Market Facts & Figures by Country
3.7.1 Latin America Sophocarpidine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sophocarpidine Sales by Country (2019-2030)
3.7.3 Latin America Sophocarpidine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sophocarpidine Market Facts & Figures by Country
3.8.1 Middle East and Africa Sophocarpidine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sophocarpidine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sophocarpidine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sophocarpidine Sales by Type (2019-2030)
4.1.1 Global Sophocarpidine Sales by Type (2019-2024)
4.1.2 Global Sophocarpidine Sales by Type (2025-2030)
4.1.3 Global Sophocarpidine Sales Market Share by Type (2019-2030)
4.2 Global Sophocarpidine Revenue by Type (2019-2030)
4.2.1 Global Sophocarpidine Revenue by Type (2019-2024)
4.2.2 Global Sophocarpidine Revenue by Type (2025-2030)
4.2.3 Global Sophocarpidine Revenue Market Share by Type (2019-2030)
4.3 Global Sophocarpidine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sophocarpidine Sales by Application (2019-2030)
5.1.1 Global Sophocarpidine Sales by Application (2019-2024)
5.1.2 Global Sophocarpidine Sales by Application (2025-2030)
5.1.3 Global Sophocarpidine Sales Market Share by Application (2019-2030)
5.2 Global Sophocarpidine Revenue by Application (2019-2030)
5.2.1 Global Sophocarpidine Revenue by Application (2019-2024)
5.2.2 Global Sophocarpidine Revenue by Application (2025-2030)
5.2.3 Global Sophocarpidine Revenue Market Share by Application (2019-2030)
5.3 Global Sophocarpidine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fujie Pharmaceutical
6.1.1 Fujie Pharmaceutical Corporation Information
6.1.2 Fujie Pharmaceutical Description and Business Overview
6.1.3 Fujie Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fujie Pharmaceutical Sophocarpidine Product Portfolio
6.1.5 Fujie Pharmaceutical Recent Developments/Updates
6.2 QHL Pharma
6.2.1 QHL Pharma Corporation Information
6.2.2 QHL Pharma Description and Business Overview
6.2.3 QHL Pharma Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 QHL Pharma Sophocarpidine Product Portfolio
6.2.5 QHL Pharma Recent Developments/Updates
6.3 Select Botanical
6.3.1 Select Botanical Corporation Information
6.3.2 Select Botanical Description and Business Overview
6.3.3 Select Botanical Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Select Botanical Sophocarpidine Product Portfolio
6.3.5 Select Botanical Recent Developments/Updates
6.4 Indena
6.4.1 Indena Corporation Information
6.4.2 Indena Description and Business Overview
6.4.3 Indena Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indena Sophocarpidine Product Portfolio
6.4.5 Indena Recent Developments/Updates
6.5 TIANSHAN Pharmaceuticals
6.5.1 TIANSHAN Pharmaceuticals Corporation Information
6.5.2 TIANSHAN Pharmaceuticals Description and Business Overview
6.5.3 TIANSHAN Pharmaceuticals Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TIANSHAN Pharmaceuticals Sophocarpidine Product Portfolio
6.5.5 TIANSHAN Pharmaceuticals Recent Developments/Updates
6.6 Selco Wirkstoffe Vertriebs GmbH
6.6.1 Selco Wirkstoffe Vertriebs GmbH Corporation Information
6.6.2 Selco Wirkstoffe Vertriebs GmbH Description and Business Overview
6.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Portfolio
6.6.5 Selco Wirkstoffe Vertriebs GmbH Recent Developments/Updates
6.7 Jiangsu Tiansheng Pharmaceutical
6.6.1 Jiangsu Tiansheng Pharmaceutical Corporation Information
6.6.2 Jiangsu Tiansheng Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
6.7.5 Jiangsu Tiansheng Pharmaceutical Recent Developments/Updates
6.8 Tiansheng Pharmaceutical
6.8.1 Tiansheng Pharmaceutical Corporation Information
6.8.2 Tiansheng Pharmaceutical Description and Business Overview
6.8.3 Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
6.8.5 Tiansheng Pharmaceutical Recent Developments/Updates
6.9 Hubei Zhongliao Chemical Co., LTD
6.9.1 Hubei Zhongliao Chemical Co., LTD Corporation Information
6.9.2 Hubei Zhongliao Chemical Co., LTD Description and Business Overview
6.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Portfolio
6.9.5 Hubei Zhongliao Chemical Co., LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sophocarpidine Industry Chain Analysis
7.2 Sophocarpidine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sophocarpidine Production Mode & Process
7.4 Sophocarpidine Sales and Marketing
7.4.1 Sophocarpidine Sales Channels
7.4.2 Sophocarpidine Distributors
7.5 Sophocarpidine Customers
8 Sophocarpidine Market Dynamics
8.1 Sophocarpidine Industry Trends
8.2 Sophocarpidine Market Drivers
8.3 Sophocarpidine Market Challenges
8.4 Sophocarpidine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
